Stocks
Intersect ENT, Inc.XENT
NASDAQHealthcareBiotechnology$28.24+0.00%
Price as of · delayed, not real-time
Specializing in ear, nose, and throat (ENT) treatments, the company develops innovative drug-eluting implants for chronic sinusitis and other ENT conditions. Investors track its progress due to its focus on minimally invasive solutions and its potential to disrupt traditional ENT care.
Market Cap: $052W Range: $15.92-$28.25
Congressional Interest in Intersect ENT, Inc. (XENT)
1 member of Congress has disclosed 1 trade in Intersect ENT, Inc. (XENT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading XENT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-03-06 | Donna Shalala | buy | $1K-$15K |